Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multi-Omics Analysis Showed the Clinical Value of Gene Signatures of C1QC+ and SPP1+ TAMs in Cervical Cancer.

Frontiers in immunology - 1 Jan 2021

Li Xiong, Zhang Qinghua, Chen Gang, Luo Danfeng

Abstract excerpt

Purpose: To evaluate the value of C1QC+ and SPP1+ TAMs gene signatures in patients with cervical cancer. Methods: We compare the C1QC+ and SPP1+ TAMs gene signatures with the M1/M2 gene signatures at single cell level and bulk RNA-seq level and evaluate which gene signature can clearly divide TAMs and patients with cervical cancer into distinct clinical subclusters better. Results: At single-cell level, C1QC+ and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Decision-Making
Share to Complement C1q
Share to Immunotherapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Osteopontin

Share to RNA-Seq

Share to Single-Cell Analysis

Share to Tumor-Associated Macrophages

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 34295336
DOI: 10.3389/fimmu.2021.694801
PMCID: PMC8290180

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multi-Omics Analysis Showed the Clinical Value of Gene Signatures of C1QC+ and SPP1+ TAMs in Cervical Cancer.PMID 34295336Read ↗

Identification and Verification of a Four-Gene Signature Predicting Overall Survival for Cervical CancerSemantic proximity Read ↗

Immune‐related Long Noncoding RNA Signature for Patients with Cervical CancerSemantic proximity Read ↗

Identification of prognosis-related genes in the cervical cancer immune microenvironmentSemantic proximity Read ↗

Identification of prognostic genes associated with innate lymphoid cells in cervical cancer through bioinformatics analyses and experimental assaysSemantic proximity Read ↗

Comprehensive Analysis to Identify SPP1 as a Prognostic Biomarker in Cervical CancerSemantic proximity Read ↗

29 immune-related genes pairs signature predict the prognosis of cervical cancer patientsSemantic proximity Read ↗

Deciphering the cellular and molecular landscape of cervical cancer progression through single-cell and spatial transcriptomicsSemantic proximity Read ↗

Integrative Systems Biology Approaches to Identify Potential Biomarkers and Pathways of Cervical CancerSemantic proximity Read ↗

Multi-Omics Data Analyses Construct a Six Immune-Related Genes Prognostic Model for Cervical Cancer in Tumor MicroenvironmentSemantic proximity Read ↗

Cervical cancer immune infiltration microenvironment identification, construction of immune scores, assisting patient prognosis and immunotherapySemantic proximity Read ↗

Decoding the tumor microenvironment and molecular mechanism: unraveling cervical cancer subpopulations and prognostic signatures through scRNA-Seq and bulk RNA-seq analysesSemantic proximity Read ↗

Identification of a novel six‐gene signature with potential prognostic and therapeutic value in cervical cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.